ArticleBioengineering (Basel, Switzerland)2026
SafeRx: A Canonical Pharmaceutical Knowledge Integration Framework for Multimodal Medication Safety.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication-related harm remains a major patient-safety challenge, substantially driven by fragmented pharmacovigilance ecosystems, inconsistent drug nomenclature, heterogeneous interaction knowledge bases, and the absence of unified multimodal medication-safety infrastructures. Existing clinical decision-support systems frequently remain interaction-centered, with limited integration of complementary safety domains such as lactation risk assessment, intravenous compatibility evaluation, and regulatory toxicity overlays. This study aimed to develop and evaluate SafeRx, a provenance-aware pharmaceutical knowledge integration platform designed to harmonize heterogeneous medication-safety data within a unified canonical framework. SafeRx integrated Romanian regulatory product summaries, Danish drug-drug interaction repositories, OpenFDA boxed warning datasets, LactMed lactation safety records, and Stabilis intravenous compatibility data through automated extraction pipelines, ontology-aware canonical substance normalization, AI-assisted semantic enrichment, and pharmacist-supervised governance workflows. The platform consolidated 2190 canonical substances linked to 9463 validated identifier mappings, 9932 canonical interaction pairs enriched with tier-based prioritization and mechanism-aware annotations, 514 regulatory boxed warning records, 1895 lactation safety entries, and 9088 intravenous compatibility records. SafeRx demonstrates the feasibility of constructing an interoperable, explainable, and pharmacist-supervised medication-safety infrastructure capable of integrating heterogeneous regulatory, pharmacologic, reproductive, and physicochemical safety domains within a unified clinically navigable framework for research, pharmacovigilance, and clinical decision-support applications. Future studies should evaluate prospective clinical implementation, electronic health record interoperability, and the real-world impact of tier-based prioritization on prescribing workflows, alert fatigue, and medication-safety outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.